Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-25-056986
Filing Date
2025-06-05
Accepted
2025-06-05 21:44:38
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517328-2_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2517328-2_4aseq1.xml 4/A 4625
  Complete submission text file 0001104659-25-056986.txt   6130
Mailing Address 84 WATERFORD DRIVE MARLBOROUGH MA 01752
Business Address
Iwicki Mark T (Reporting) CIK: 0001415537 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38150 | Film No.: 251028731

Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)